An About Face As Biogen Says It Will File Aducanumab In Alzheimer’s

 
• By Mandy Jackson
  
Profile of a human head with a colorful symbol of neurons in the brain
Biogen revived once-discontinued aducanumab and plans to file for US FDA approval. • Source: Shutterstock

More from Clinical Trials

More from R&D